ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Start-ups

The class of 2015: Where are they now?

An update on the diverse technologies featured last year

by Lisa M. Jarvis
October 26, 2016 | APPEARED IN VOLUME 94, ISSUE 43

C &EN’s inaugural class of 10 Start-ups to Watch has been busy raising money and advancing technologies. Here are highlights from the young companies we profiled last year.

Bolt Threads, a synthetic spider silk developer, raised $82.3 million across two rounds of funding this spring and also inked a deal with luxury sportswear firm Patagonia.

Carbon3D, a three-dimensional printing company, raised the curtains on its first commercial 3-D printer, dubbed the M1, and raised $81 million in its third round of funding. The firm also signed deals with Eastman Kodak and Johnson & Johnson.

Connora Technologies, which develops epoxy hardeners that render carbon fiber composites recyclable, last month signed a pact with Aditya Birla Chemicals, a leading epoxy resin producer. The partners are developing a metric-ton-scale manufacturing process for Connora’s epoxy thermoset technology.

Know a start-up we should consider for next year's list? Nominate it here: cenm.ag/startupnom

NOHMs Technologies, which is developing ionic liquid electrolytes and carbon-sulfur cathodes for safer, longer-lasting batteries, closed a $5 million Series B financing round backed by Phoenix Venture Partners, Solvay, the New York State Innovation Venture Capital Fund, and angel investors.

Padlock Therapeutics, a biotech firm focused on developing protein arginine deiminase modulators, was acquired by Bristol-Myers Squibb in March. The deal valued Padlock at up to $600 million.

SLIPS Technologies saw its surface enhancement products move out of the lab and into the marketplace. SLIPS films are now installed on a glass skyscraper in Manhattan to help prevent ice buildup. Clinicians at a Boston teaching hospital are using SLIPS-coated scopes to prevent blood and mucus buildup during surgery.

Twist Bioscience, a biotech with silicon-based DNA synthesis technology, enhanced its gene design capabilities with the acquisition of Israeli software firm Genome Compiler. Twist also raised $61 million in funding and secured synthetic DNA pacts with Microsoft and Ginkgo Bioworks.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment